The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Pet Medical Cannabidiol Market Research Report 2025
Synopsis
Pet Medical Cannabidiol, or Pet CBD, is a term that refers to products derived from the cannabis plant that are intended to be used for animals, such as dogs and cats. CBD is short for cannabidiol, which is one of the many active compounds found in cannabis. Unlike THC, which is another compound in cannabis that causes psychoactive effects, CBD does not make animals or humans high. CBD is believed to have various health benefits for pets, such as reducing anxiety, pain, inflammation, and seizures. However, the scientific evidence for these claims is still limited and more research is needed to confirm the safety and efficacy of CBD for pets.
Global Pet Medical Cannabidiol market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Pet Medical Cannabidiol market research.
Key manufacturers engaged in the Pet Medical Cannabidiol industry include Canna-Pet, Holistic Hound, BATCH, Choom Holdings, Receptra Naturals, Curaleaf, Trulieve Cannabis, Pure Spectrum and Cannabis Strategies Acquisition, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Pet Medical Cannabidiol were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Pet Medical Cannabidiol market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Pet Medical Cannabidiol market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Canna-Pet
Holistic Hound
BATCH
Choom Holdings
Receptra Naturals
Curaleaf
Trulieve Cannabis
Pure Spectrum
Cannabis Strategies Acquisition
Pet Releaf
Diamond CBD
PotNetwork Holdings
Kat's Naturals
Bluebird Botanicals
Segment by Type
Oral Cannabidiol
Topical Cannabidiol
Segment by Application
Anaesthetization
Stimulate Appetite
Relieve Anxiety
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Pet Medical Cannabidiol report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Pet Medical Cannabidiol, or Pet CBD, is a term that refers to products derived from the cannabis plant that are intended to be used for animals, such as dogs and cats. CBD is short for cannabidiol, which is one of the many active compounds found in cannabis. Unlike THC, which is another compound in cannabis that causes psychoactive effects, CBD does not make animals or humans high. CBD is believed to have various health benefits for pets, such as reducing anxiety, pain, inflammation, and seizures. However, the scientific evidence for these claims is still limited and more research is needed to confirm the safety and efficacy of CBD for pets.
Global Pet Medical Cannabidiol market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Pet Medical Cannabidiol market research.
Key manufacturers engaged in the Pet Medical Cannabidiol industry include Canna-Pet, Holistic Hound, BATCH, Choom Holdings, Receptra Naturals, Curaleaf, Trulieve Cannabis, Pure Spectrum and Cannabis Strategies Acquisition, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Pet Medical Cannabidiol were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Pet Medical Cannabidiol market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Pet Medical Cannabidiol market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Canna-Pet
Holistic Hound
BATCH
Choom Holdings
Receptra Naturals
Curaleaf
Trulieve Cannabis
Pure Spectrum
Cannabis Strategies Acquisition
Pet Releaf
Diamond CBD
PotNetwork Holdings
Kat's Naturals
Bluebird Botanicals
Segment by Type
Oral Cannabidiol
Topical Cannabidiol
Segment by Application
Anaesthetization
Stimulate Appetite
Relieve Anxiety
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Pet Medical Cannabidiol report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Pet Medical Cannabidiol Market Overview
1.1 Product Overview and Scope of Pet Medical Cannabidiol
1.2 Pet Medical Cannabidiol Segment by Type
1.2.1 Global Pet Medical Cannabidiol Market Value Comparison by Type (2023-2029)
1.2.2 Oral Cannabidiol
1.2.3 Topical Cannabidiol
1.3 Pet Medical Cannabidiol Segment by Application
1.3.1 Global Pet Medical Cannabidiol Market Value by Application: (2023-2029)
1.3.2 Anaesthetization
1.3.3 Stimulate Appetite
1.3.4 Relieve Anxiety
1.3.5 Others
1.4 Global Pet Medical Cannabidiol Market Size Estimates and Forecasts
1.4.1 Global Pet Medical Cannabidiol Revenue 2018-2029
1.4.2 Global Pet Medical Cannabidiol Sales 2018-2029
1.4.3 Global Pet Medical Cannabidiol Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Pet Medical Cannabidiol Market Competition by Manufacturers
2.1 Global Pet Medical Cannabidiol Sales Market Share by Manufacturers (2018-2023)
2.2 Global Pet Medical Cannabidiol Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Pet Medical Cannabidiol Average Price by Manufacturers (2018-2023)
2.4 Global Pet Medical Cannabidiol Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Pet Medical Cannabidiol, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pet Medical Cannabidiol, Product Type & Application
2.7 Pet Medical Cannabidiol Market Competitive Situation and Trends
2.7.1 Pet Medical Cannabidiol Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Pet Medical Cannabidiol Players Market Share by Revenue
2.7.3 Global Pet Medical Cannabidiol Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pet Medical Cannabidiol Retrospective Market Scenario by Region
3.1 Global Pet Medical Cannabidiol Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Pet Medical Cannabidiol Global Pet Medical Cannabidiol Sales by Region: 2018-2029
3.2.1 Global Pet Medical Cannabidiol Sales by Region: 2018-2023
3.2.2 Global Pet Medical Cannabidiol Sales by Region: 2024-2029
3.3 Global Pet Medical Cannabidiol Global Pet Medical Cannabidiol Revenue by Region: 2018-2029
3.3.1 Global Pet Medical Cannabidiol Revenue by Region: 2018-2023
3.3.2 Global Pet Medical Cannabidiol Revenue by Region: 2024-2029
3.4 North America Pet Medical Cannabidiol Market Facts & Figures by Country
3.4.1 North America Pet Medical Cannabidiol Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Pet Medical Cannabidiol Sales by Country (2018-2029)
3.4.3 North America Pet Medical Cannabidiol Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pet Medical Cannabidiol Market Facts & Figures by Country
3.5.1 Europe Pet Medical Cannabidiol Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Pet Medical Cannabidiol Sales by Country (2018-2029)
3.5.3 Europe Pet Medical Cannabidiol Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pet Medical Cannabidiol Market Facts & Figures by Country
3.6.1 Asia Pacific Pet Medical Cannabidiol Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Pet Medical Cannabidiol Sales by Country (2018-2029)
3.6.3 Asia Pacific Pet Medical Cannabidiol Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Pet Medical Cannabidiol Market Facts & Figures by Country
3.7.1 Latin America Pet Medical Cannabidiol Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Pet Medical Cannabidiol Sales by Country (2018-2029)
3.7.3 Latin America Pet Medical Cannabidiol Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pet Medical Cannabidiol Market Facts & Figures by Country
3.8.1 Middle East and Africa Pet Medical Cannabidiol Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Pet Medical Cannabidiol Sales by Country (2018-2029)
3.8.3 Middle East and Africa Pet Medical Cannabidiol Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pet Medical Cannabidiol Sales by Type (2018-2029)
4.1.1 Global Pet Medical Cannabidiol Sales by Type (2018-2023)
4.1.2 Global Pet Medical Cannabidiol Sales by Type (2024-2029)
4.1.3 Global Pet Medical Cannabidiol Sales Market Share by Type (2018-2029)
4.2 Global Pet Medical Cannabidiol Revenue by Type (2018-2029)
4.2.1 Global Pet Medical Cannabidiol Revenue by Type (2018-2023)
4.2.2 Global Pet Medical Cannabidiol Revenue by Type (2024-2029)
4.2.3 Global Pet Medical Cannabidiol Revenue Market Share by Type (2018-2029)
4.3 Global Pet Medical Cannabidiol Price by Type (2018-2029)
5 Segment by Application
5.1 Global Pet Medical Cannabidiol Sales by Application (2018-2029)
5.1.1 Global Pet Medical Cannabidiol Sales by Application (2018-2023)
5.1.2 Global Pet Medical Cannabidiol Sales by Application (2024-2029)
5.1.3 Global Pet Medical Cannabidiol Sales Market Share by Application (2018-2029)
5.2 Global Pet Medical Cannabidiol Revenue by Application (2018-2029)
5.2.1 Global Pet Medical Cannabidiol Revenue by Application (2018-2023)
5.2.2 Global Pet Medical Cannabidiol Revenue by Application (2024-2029)
5.2.3 Global Pet Medical Cannabidiol Revenue Market Share by Application (2018-2029)
5.3 Global Pet Medical Cannabidiol Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Canna-Pet
6.1.1 Canna-Pet Corporation Information
6.1.2 Canna-Pet Description and Business Overview
6.1.3 Canna-Pet Pet Medical Cannabidiol Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Canna-Pet Pet Medical Cannabidiol Product Portfolio
6.1.5 Canna-Pet Recent Developments/Updates
6.2 Holistic Hound
6.2.1 Holistic Hound Corporation Information
6.2.2 Holistic Hound Description and Business Overview
6.2.3 Holistic Hound Pet Medical Cannabidiol Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Holistic Hound Pet Medical Cannabidiol Product Portfolio
6.2.5 Holistic Hound Recent Developments/Updates
6.3 BATCH
6.3.1 BATCH Corporation Information
6.3.2 BATCH Description and Business Overview
6.3.3 BATCH Pet Medical Cannabidiol Sales, Revenue and Gross Margin (2018-2023)
6.3.4 BATCH Pet Medical Cannabidiol Product Portfolio
6.3.5 BATCH Recent Developments/Updates
6.4 Choom Holdings
6.4.1 Choom Holdings Corporation Information
6.4.2 Choom Holdings Description and Business Overview
6.4.3 Choom Holdings Pet Medical Cannabidiol Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Choom Holdings Pet Medical Cannabidiol Product Portfolio
6.4.5 Choom Holdings Recent Developments/Updates
6.5 Receptra Naturals
6.5.1 Receptra Naturals Corporation Information
6.5.2 Receptra Naturals Description and Business Overview
6.5.3 Receptra Naturals Pet Medical Cannabidiol Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Receptra Naturals Pet Medical Cannabidiol Product Portfolio
6.5.5 Receptra Naturals Recent Developments/Updates
6.6 Curaleaf
6.6.1 Curaleaf Corporation Information
6.6.2 Curaleaf Description and Business Overview
6.6.3 Curaleaf Pet Medical Cannabidiol Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Curaleaf Pet Medical Cannabidiol Product Portfolio
6.6.5 Curaleaf Recent Developments/Updates
6.7 Trulieve Cannabis
6.6.1 Trulieve Cannabis Corporation Information
6.6.2 Trulieve Cannabis Description and Business Overview
6.6.3 Trulieve Cannabis Pet Medical Cannabidiol Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Trulieve Cannabis Pet Medical Cannabidiol Product Portfolio
6.7.5 Trulieve Cannabis Recent Developments/Updates
6.8 Pure Spectrum
6.8.1 Pure Spectrum Corporation Information
6.8.2 Pure Spectrum Description and Business Overview
6.8.3 Pure Spectrum Pet Medical Cannabidiol Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Pure Spectrum Pet Medical Cannabidiol Product Portfolio
6.8.5 Pure Spectrum Recent Developments/Updates
6.9 Cannabis Strategies Acquisition
6.9.1 Cannabis Strategies Acquisition Corporation Information
6.9.2 Cannabis Strategies Acquisition Description and Business Overview
6.9.3 Cannabis Strategies Acquisition Pet Medical Cannabidiol Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Cannabis Strategies Acquisition Pet Medical Cannabidiol Product Portfolio
6.9.5 Cannabis Strategies Acquisition Recent Developments/Updates
6.10 Pet Releaf
6.10.1 Pet Releaf Corporation Information
6.10.2 Pet Releaf Description and Business Overview
6.10.3 Pet Releaf Pet Medical Cannabidiol Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Pet Releaf Pet Medical Cannabidiol Product Portfolio
6.10.5 Pet Releaf Recent Developments/Updates
6.11 Diamond CBD
6.11.1 Diamond CBD Corporation Information
6.11.2 Diamond CBD Pet Medical Cannabidiol Description and Business Overview
6.11.3 Diamond CBD Pet Medical Cannabidiol Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Diamond CBD Pet Medical Cannabidiol Product Portfolio
6.11.5 Diamond CBD Recent Developments/Updates
6.12 PotNetwork Holdings
6.12.1 PotNetwork Holdings Corporation Information
6.12.2 PotNetwork Holdings Pet Medical Cannabidiol Description and Business Overview
6.12.3 PotNetwork Holdings Pet Medical Cannabidiol Sales, Revenue and Gross Margin (2018-2023)
6.12.4 PotNetwork Holdings Pet Medical Cannabidiol Product Portfolio
6.12.5 PotNetwork Holdings Recent Developments/Updates
6.13 Kat's Naturals
6.13.1 Kat's Naturals Corporation Information
6.13.2 Kat's Naturals Pet Medical Cannabidiol Description and Business Overview
6.13.3 Kat's Naturals Pet Medical Cannabidiol Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Kat's Naturals Pet Medical Cannabidiol Product Portfolio
6.13.5 Kat's Naturals Recent Developments/Updates
6.14 Bluebird Botanicals
6.14.1 Bluebird Botanicals Corporation Information
6.14.2 Bluebird Botanicals Pet Medical Cannabidiol Description and Business Overview
6.14.3 Bluebird Botanicals Pet Medical Cannabidiol Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Bluebird Botanicals Pet Medical Cannabidiol Product Portfolio
6.14.5 Bluebird Botanicals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pet Medical Cannabidiol Industry Chain Analysis
7.2 Pet Medical Cannabidiol Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pet Medical Cannabidiol Production Mode & Process
7.4 Pet Medical Cannabidiol Sales and Marketing
7.4.1 Pet Medical Cannabidiol Sales Channels
7.4.2 Pet Medical Cannabidiol Distributors
7.5 Pet Medical Cannabidiol Customers
8 Pet Medical Cannabidiol Market Dynamics
8.1 Pet Medical Cannabidiol Industry Trends
8.2 Pet Medical Cannabidiol Market Drivers
8.3 Pet Medical Cannabidiol Market Challenges
8.4 Pet Medical Cannabidiol Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Retail Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
